Cargando…
Iguratimod Inhibits the Aggressiveness of Rheumatoid Fibroblast-Like Synoviocytes
OBJECTIVE: Iguratimod, a novel disease-modifying anti-rheumatic drug for the treatment of rheumatoid arthritis, has been approved in China and Japan. Here, we aimed to find whether iguratimod can inhibit the aggressive behavior and promote apoptosis of rheumatoid fibroblast-like synoviocytes (RA-FLS...
Autores principales: | Lin, Jin, Yu, Ye, Wang, Xuanwei, Ke, Yini, Sun, Chuanyin, Yue, Lihuan, Xu, Guanhua, Xu, Bei, Xu, Liqin, Cao, Heng, Xu, Danyi, Olsen, Nancy, Chen, Weiqian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885276/ https://www.ncbi.nlm.nih.gov/pubmed/31828173 http://dx.doi.org/10.1155/2019/6929286 |
Ejemplares similares
-
Local and Systemic IKKε and NF-κB Signaling Associated with Sjögren's Syndrome Immunopathogenesis
por: Chen, Weiqian, et al.
Publicado: (2015) -
Mucin 1 aggravates synovitis and joint damage of rheumatoid arthritis by regulating inflammation and aggression of fibroblast-like synoviocytes
por: Zou, Yaoyao, et al.
Publicado: (2022) -
Features and Outcomes of Elderly Rheumatoid Arthritis: Does the Age of Onset Matter? A Comparative Study From a Single Center in China
por: Ke, Yini, et al.
Publicado: (2020) -
Efficacy and Safety of Iguratimod for the Treatment of Rheumatoid Arthritis
por: Li, Jiangtao, et al.
Publicado: (2013) -
Caspase‐8 Variant G Regulates Rheumatoid Arthritis Fibroblast‐Like Synoviocyte Aggressive Behavior
por: Ansalone, Cecilia, et al.
Publicado: (2021)